Athanor Capital, LP Rocket Pharmaceuticals, Inc. Transaction History

Athanor Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $268,736 - $322,197	-6,819 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$43.34 - $65.91 $28,604 - $43,500	660 Added 10.72%	6,819 $303,000
Q4 2020 Feb 16, 2021	SELL	$23.3 - $59.57 $61,768 - $157,920	-2,651 Reduced 30.09%	6,159 $338,000
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $57,830 - $80,652	-2,821 Reduced 24.25%	8,810 $201,000
Q2 2020 Aug 13, 2020	BUY	$13.32 - $22.61 $154,924 - $262,976	11,631 New	11,631 $243,000
Q1 2020 May 14, 2020	SELL	$9.71 - $25.11 $104,877 - $271,213	-10,801 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $119,567 - $261,708	10,801 New	10,801 $246,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.